Amethyst Radiotherapy
Amethyst Radiotherapy Group operates 15 specialist cancer treatment centres across six European countries, delivering radiotherapy, radiosurgery, brachytherapy and chemotherapy services to cancer patients within the Stingray Healthcare Group platform.
- Company typePrivate
- Founded2010
- HeadquartersCompiègne, France
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Amethyst Radiotherapy does
Amethyst Radiotherapy Group (legal entity) operates a European network of radiotherapy clinics delivering advanced radiation therapy, radiosurgery, brachytherapy and chemotherapy services to cancer patients. Founded in 2010 and headquartered in the Netherlands (with its founding base in Compiègne, France), the company runs 15 specialist treatment centres across six countries — Austria, France, Italy, Poland, Romania and the United Kingdom — staffed by multidisciplinary clinical teams that tailor treatment plans to individual patients. Its technology stack centres on advanced radiotherapy modalities, and the group has publicly positioned AI-enabled radiotherapy planning as a tool to improve precision and expand treatment capacity, though no proprietary AI research or model disclosures are available.
Amethyst sits within the Stingray Healthcare Group, Europe's largest independent cancer care platform headquartered in Lausanne, Switzerland, which operates more than 30 centres across eight European countries and treats approximately 40,000 patients per year. Under a partnership-led model, Amethyst works with healthcare professionals and institutional partners — preserving clinical independence while modernising oncology infrastructure through long-term investment and technology upgrades. The group invests in equipment, clinical best-practice sharing and integration across centres, with acquired subsidiaries (e.g., Medical Equipment Solutions Ltd, 2020) supporting equipment lifecycle capabilities.
Revenue is generated through fee-for-service radiotherapy and oncology treatments, with pricing negotiated through national healthcare systems, insurance providers and government health programmes rather than published rate cards. Distribution is direct via owned treatment centres (a Direct Sales / field enterprise channel targeting health systems), supplemented by institutional referral partnerships and healthcare professional relationships. Capital structure has been progressively built through a 2015 Accession Capital Partners round (~€23.5M), a 2019 Rohatyn Group round, and a June 2024 €300M debt facility from Credit funds managed by Ares Management Corporation, primarily to fund further European expansion and radiotherapy technology investment.
Amethyst Radiotherapy firmographics
Firmographics- Name
- Amethyst Radiotherapy
- Legal name
- Amethyst Radiotherapy Group
- Website
- https://amethyst-radiotherapy.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Amethyst Radiotherapy Group operates 15 specialist cancer treatment centres across six European countries, delivering radiotherapy, radiosurgery, brachytherapy and chemotherapy services to cancer patients within the Stingray Healthcare Group platform.
- Ownership category
- akta.pro rank
Amethyst Radiotherapy industry classification
Industry- Product category
- Radiotherapy & Cancer Treatment Services
- NAICS
- Ambulatory Health Care Services (621), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Radiation Oncology (HLAKAFAC)
- akta.pro secondary industries
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Oncology & Cancer Specialty Hospitals (HLAFAHAC), Medical Oncology (HLAKAFAB), Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI)
Keywords
Where Amethyst Radiotherapy is headquartered
LocationHeadquarters
- HQ city
- Compiègne
- HQ country
- France
- HQ region
- Europe
Offices7 records
Markets served
Amethyst Radiotherapy business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Infrastructure, Technology or R&D, Operations, Supply Chain
Revenue model
- Radiotherapy Treatment Services: Amethyst generates revenue through providing radiotherapy and oncology treatment services across its network of treatment centers in Europe. Services include radiotherapy, radiosurgery, brachytherapy and chemotherapy treatments tailored to individual patients by multidisciplinary clinical teams.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Amethyst Radiotherapy product offering
Product offeringCore offering
Amethyst Radiotherapy Group operates a pan-European network of 15 specialized cancer treatment centers providing external beam radiotherapy, stereotactic radiosurgery (CyberKnife), brachytherapy, and chemotherapy. Services are delivered through partnerships with healthcare professionals and institutions across Austria, France, Italy, Poland, Romania, and the United Kingdom, with treatment plans tailored to individual oncology patients.
Product overview
Amethyst Radiotherapy operates as a radiotherapy operator offering a comprehensive suite of cancer treatment services. The company functions as a single-service offering (radiotherapy-centred oncology care) with treatment modalities including radiotherapy, radiosurgery, brachytherapy, and chemotherapy. These services are delivered across multiple specialist treatment centres in six European countries, with treatments tailored to individual patients by multidisciplinary clinical teams.
Differentiator
Problem solved
Functional benefit
Products and services
- External Beam Radiotherapy
Quantifiable outcome
- Expanded access to high-quality oncology services across Europe
Companies that use Amethyst Radiotherapy
Customer profileSegments1 record
Ideal customer profiles2 records
Amethyst Radiotherapy technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Amethyst Radiotherapy partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Stingray Healthcare GroupcoreAmethyst operates as part of the Stingray Healthcare Group network, Europe's largest independent cancer care platform. The partnership enables sharing of clinical best practices, innovation, and high-quality cancer care at scale across European radiotherapy centres.
Scale indicators3 records
Recent moves7 records
Expansion highlights5 records
Amethyst Radiotherapy competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key highlights6 records
Customer concentration
Amethyst Radiotherapy social profiles
Digital presenceAmethyst Radiotherapy financial estimates
Financial estimateRevenue estimate
Valuation estimate
Amethyst Radiotherapy leadership team
Management profileNumber of profiles
Profiles3 records
Amethyst Radiotherapy funding detail
Funding detailFunding overview
Funding rounds3 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Amethyst Radiotherapy M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Amethyst Radiotherapy
What does Amethyst Radiotherapy do?
Amethyst Radiotherapy Group operates a pan-European network of 15 specialized cancer treatment centers providing external beam radiotherapy, stereotactic radiosurgery (CyberKnife), brachytherapy, and chemotherapy. Services are delivered through partnerships with healthcare professionals and institutions across Austria, France, Italy, Poland, Romania, and the United Kingdom, with treatment plans tailored to individual oncology patients.
Is Amethyst Radiotherapy a public or private company?
Amethyst Radiotherapy is a private company. It is classified as private equity controlled and is currently operating.
When was Amethyst Radiotherapy founded?
Amethyst Radiotherapy was founded in 2010. It employs 11 to 50 people.
Where is Amethyst Radiotherapy based?
Amethyst Radiotherapy is headquartered in Compiègne, France, in the Europe region.
How does Amethyst Radiotherapy make money?
One revenue line is on record: radiotherapy Treatment Services.
Does Amethyst Radiotherapy have an API?
No public API is recorded for Amethyst Radiotherapy.
What industry is Amethyst Radiotherapy in?
Amethyst Radiotherapy's product category is Radiotherapy & Cancer Treatment Services. Its primary akta.pro industry code is HLAKAFAC, Radiation Oncology, with a secondary code of HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation). Its NAICS code is 621 and its SIC code is 8093.